Human Metabolome Technologies, Inc. (JP:6090) has released an update.
Human Metabolome Technologies, Inc. reports a slight increase in net sales and operating profit for June 2024 compared to the previous year, but a significant decrease in profit attributable to owners. The company’s total assets grew, yet the capital adequacy ratio and return on equity saw a slight decline. Cash flow from operations decreased, but there was an overall rise in cash and equivalents by the end of the period.
For further insights into JP:6090 stock, check out TipRanks’ Stock Analysis page.
